Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rasagiline (AGN1135) is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 34.00 | |
25 mg | In stock | $ 55.00 | |
50 mg | In stock | $ 80.00 | |
100 mg | In stock | $ 105.00 | |
200 mg | In stock | $ 142.00 | |
500 mg | In stock | $ 236.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 39.00 |
Description | Rasagiline (AGN1135) is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease. |
Targets&IC50 | MAO-A:412 nM, MAO-B:4.43 nM |
Synonyms | AGN1135, TVP1012 |
Molecular Weight | 171.24 |
Formula | C12H13N |
CAS No. | 136236-51-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 23.4 mM
DMSO: 198.6 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rasagiline 136236-51-6 Apoptosis Metabolism Neuroscience BCL MAO Monoamine Oxidase inhibit TVP 1012 AGN1135 AGN-1135 (R)-AGN1135 Inhibitor TVP1012 AGN 1135 TVP-1012 inhibitor